The current MTNB market cap is 39.59M. The company's latest EPS is USD -0.1056 and P/E is -1.70.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.06M | 1.06M | 1.1M | 0 | 0 |
Operating Income | -5.46M | -5.48M | -5.59M | -6.16M | -6.13M |
Net Income | -5.46M | -3.64M | -5.51M | -6.06M | -6.06M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 90k | 158k | 33k | 3.19M | 1.1M |
Operating Income | -18.92M | -24.21M | -24.74M | -24.59M | -23.77M |
Net Income | -18.3M | -23.24M | -23.68M | -21M | -22.94M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 47.55M | 44.82M | 38.26M | 34.03M | 29.79M |
Total Liabilities | 8.93M | 8.18M | 5.64M | 6.17M | 6.64M |
Total Equity | 38.62M | 36.64M | 32.63M | 27.85M | 23.15M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 40.24M | 70.97M | 61.33M | 44.82M | 25.1M |
Total Liabilities | 7.19M | 7.24M | 8.83M | 8.18M | 5.86M |
Total Equity | 33.05M | 63.73M | 52.49M | 36.64M | 19.25M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -14.86M | -19.16M | -4.09M | -6.28M | -10.7M |
Investing | 4.92M | 4.88M | 3M | 9.2M | 10.28M |
Financing | 84k | 79k | -4k | -5k | -6k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -14.09M | -17.37M | -15.22M | -19.16M | -15.28M |
Investing | -6.01M | -40.67M | 16.77M | 4.88M | 13.24M |
Financing | 29.85M | 48.05M | 6.97M | 79k | -7k |
Market Cap | 39.59M |
Price to Earnings Ratio | -1.70 |
Price to Sales Ratio | 36 |
Price to Cash Ratio | 8.18 |
Price to Book Ratio | 2.03 |
Dividend Yield | - |
Shares Outstanding | 217.26M |
Average Volume (1 week) | 736.63k |
Average Volume (1 Month) | 1.81M |
52 Week Change | -71.97% |
52 Week High | 0.89 |
52 Week Low | 0.1103 |
Spread (Intraday) | 0 (2.04%) |
Company Name | Matinas Biopharma Holdings Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.matinasbiopharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.